🔎 Trials Near Me

홈 › 과체중 › 텍사스 › Houston

TX Houston의 과체중 임상 시험

과체중 관련 연구 33개가 Houston 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.

공식 연구 텍스트(영어)

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

피험자 모집 중2상
  • PlanIt Research /ID# 282204, Houston
18세 ~ 75세 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07752979

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

피험자 모집 중3상
  • Biopharma Informatic, LLC, Houston
  • Care Access - Houston - Clinical Trials Center by Walmart & Care Access, Houston
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07794579

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

피험자 모집 중3상
  • Houston Research Institute, Houston
  • The Endocrine Center, Houston
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07668414

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

피험자 모집 중3상
  • PlanIt Research, LLC (Monitoring Room), Houston
  • PlanIt Research, LLC, Houston
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07595549

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

피험자 모집 중3상
  • McGovern Medical School, Houston
  • Texas Childrens Hospital, Houston
  • Dynamed Clinical Research, LP d/b/a DM Clinical Research, Houston
  • 외 1개
6세 ~ 17세 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06672549

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

피험자 모집 중2상
  • PlanIt Research, PLLC, Houston
18세 ~ 75세 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07589608

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

피험자 모집 중3상
  • Juno Research, Houston
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

피험자 모집 중3상
  • Research Site, Houston
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07784270

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

피험자 모집 중3상
  • Care Access - Houston, Houston
  • JCCT - Juno Bellaire Site, Bellaire · 7마일 거리
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07353931

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

피험자 모집 중3상
  • The University of Texas Health Science Center at Houston, Bellaire · 7마일 거리
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07321886

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

피험자 모집 중3상
  • Biopharma Informatic, LLC, Houston
  • Cardiovascular Specialists of Willowbrook, Houston
  • PlanIt Research, PLLC, Houston
  • 외 2개
45세 ~ 99세 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

피험자 모집 중3상
  • Juno Research, Houston
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07282600

Semaglutide for Post-Smoking Cessation Weight Management

피험자 모집 중2상건강한 지원자 환영
  • The University of Texas Health Science Center at Houston, Houston
18세 ~ 75세 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT06173778

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

피험자 모집 중3상
  • AURORA-2 Clinical Site, Houston
18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

피험자 모집 중3상
  • HRI ? Medical Center, LLC, Houston
  • Juno Research, LLC, Houston
18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

피험자 모집 중2상
  • Juno Research, Houston
18세 ~ 75세 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT06897475

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

피험자 모집 중3상
  • Elevate Clinical, Houston
  • Houston Research Institute, Houston
  • Bellaire Clinical Research, LLC, Bellaire · 7마일 거리
18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

피험자 모집 중3상건강한 지원자 환영
  • ACCOMPLISH-2 Research Site, Houston
  • ACCOMPLISH-2 Research Site, Houston
18세 ~ 79세 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT07654374

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

피험자 모집 중2상
  • Biopharma Informatic, LLC, Houston
  • PlanIt Research, PLLC, Houston
  • Research Physicians Network, LLC, Houston
18세 ~ 75세 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT07215559

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

피험자 모집 중2상
  • PlanIt Research, PLLC, Houston
18세 ~ 75세 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT06143956

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

피험자 모집 중4상
  • Center for Clinical Studies, Houston
  • Bellaire Dermatology Associates, Bellaire · 7마일 거리
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT06857942

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

피험자 모집 중3상
  • PlanIt Research, PLLC, Houston
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT07533175

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

피험자 모집 중3상
  • Kailera Clinical Site, Bellaire · 7마일 거리
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT07284875

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

피험자 모집 중3상
  • JCCT- Juno Northwest Houston, Houston
  • Johnson County Clinical Trials Juno Bellaire, Bellaire · 7마일 거리
18세 ~ 99세 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT07684144

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

피험자 모집 중3상
  • JCCT- Juno Northwest Houston, Houston
  • Biopharma Informatic, LLC, Houston
  • Johnson County Clinical Trials Juno Bellaire, Bellaire · 7마일 거리
18세 ~ 99세 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT07684235

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

피험자 모집 중3상
  • DM Clinical, Houston
8세 ~ 18세 · 모든 성별 · 2026. 8. 31. 업데이트됨 · NCT07253285

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

피험자 모집 중3상
  • Biopharma Informatic, LLC, Houston
  • Research Physicians Network, LLC, Houston
18세 ~ 99세 · 모든 성별 · 2026. 8. 27. 업데이트됨 · NCT07575399

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

피험자 모집 중3상
  • Research Site, Houston
18세 이상 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT07784725

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

피험자 모집 중3상
  • ACCOMPLISH-1 Research Site, Houston
  • ACCOMPLISH-1 Research Site, Houston
18세 ~ 79세 · 모든 성별 · 2026. 8. 10. 업데이트됨 · NCT07654361

Metformin IN Asthma for Overweight and Obese Individuals (MINA)

피험자 모집 중2상
  • Baylor College of Medicine, Houston
18세 이상 · 모든 성별 · 2026. 1. 16. 업데이트됨 · NCT06273072

다른 도시의 과체중 시험

Houston의 다른 연구

ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.